![]() ![]() From left: Northwest College wrestlers Gus Harrison, Brady Lowry, Kendell Cummings and Orrin Jackson. Thick and thin, thick and thin, for miles. and then spots where every shrub and tree seemed to have banded together and decided to form a neighborhood. ![]() They traversed areas of wide-open jagged rock. They hiked close to 15 miles in six hours that day on the Bobcat-Houlihan Trail, which sits on the outskirts of Yellowstone. The four stuck together for most of the day. They kept telling him he was going to be a blinking food sign for any aggressive wildlife in the area. They'd gone out with two other Northwest College wrestlers, Gus Harrison and Orrin Jackson, and they spent the 45-minute drive teasing Gus for wearing a bright red sweatshirt instead of camo or dark clothing. A good day of shed hunting can net a college kid $500, and today, Oct. A big set of antlers can be worth $200 or so. They both loved the outdoors, and as wrestling season started up in early October, Brady had talked to Kendell about how much money he makes doing "shed hunting." Shed hunting involves meticulously scouring the dense mountain trails near Yellowstone National Park, looking for horns that elk, moose, mule deer and other male animals lose once a year. So they started hanging out after practice. That's what it had done for Brady and Kendell. it's violence and then forgiveness, for hours on end, and that can weld two people together almost instantly. Pushing each other on 5-mile runs, sweating and bleeding all over the place, either twisting your friend into a pretzel or getting pretzeled. There's something about being wrestling practice partners that can forge lifelong friendships in six weeks. Kendell was a hardworking sophomore who hadn't cracked the lineup yet. Brady, who'd been a juco All-American as a freshman, was back on the team after taking a year off from college. The two Northwest College wrestlers had known each other for only about a month and a half, but they had become fast friends. So when Brady Lowry stumbled upon a fresh pile back in October, deep in the thick brush of the Wyoming wilderness near Yellowstone, he turned his head and began to alert Kendell Cummings. The Botox-maker’s revenue is seen increasing 39 percent this year, according to Thomson Reuters I/B/E/S estimates.WARNING: This story contains graphic descriptions of a grizzly bear attack.Ī GOOD FRIEND never lets his buddy step in bear crap. REVENUE BOOSTĪllergan would give Pfizer, whose revenues are expected to slide 3.3 percent this year, a boost in top-line growth. ![]() drugmaker, has also been suggested as a possible acquirer of GlaxoSmithKline Plc and Shire, and shares in these two companies fell 1.5 and 1.8 percent on Thursday morning in London. “When you’re the size of Pfizer, an acquisition like this may be the only choice you have in order to be able to move the needle for sequential growth.so the question now becomes, if not this, what, and if not now, when?” said WBB Securities’ analyst Stephen Brozak. attempt to crack down on such tax avoidance deals led to the collapse of AbbVie Inc’s bid to buy Shire Plc, but it is unclear whether those rule changes would preclude potential tax advantages from a Pfizer-Allergan deal. The potential for lowering Pfizer’s tax bill by switching its headquarters from the United States to the United Kingdom was touted by Chief Executive Officer Ian Read as a key reason for the proposed AstraZeneca deal.Ī takeover of Allergan could offer similar advantages given that the Botox-maker is based in lower-tax Dublin. The healthcare sector has seen an unprecedented wave of deals since early 2014, from large drugmakers buying up smaller rivals, to consolidation among makers of generic medicines and tie-ups between insurers.Ī bid for Allergan, which has a market value of $113 billion, would be Pfizer’s second recent attempt to acquire a big rival, following its unsuccessful courtship last year of Anglo-Swedish pharmaceuticals group AstraZeneca Plc.Ĭombining Allergan and Pfizer, which is worth $219 billion, would create the world’s largest healthcare group with a market value of around $330 billion, ahead of Johnson & Johnson on $278 billion.Ī Pfizer spokesman said it “does not comment on market rumour and speculation”. A man walks past Pfizer's world headquarters in New York April 28, 2014. ![]()
0 Comments
Leave a Reply. |